Centre de Recherche du CHU-Sainte-Justine, Montreal, Quebec, Canada.
Department of Pathology and Cell biology, University of Montreal, Montreal, Quebec, Canada.
PeerJ. 2022 Jul 8;10:e13721. doi: 10.7717/peerj.13721. eCollection 2022.
Coronaviruses have been at the forefront of the news for the last 2 years. Unfortunately, SARS-CoV-2, the etiologic agent for the COVID-19 pandemic, must be manipulated in biosecurity level 3 settings, which significantly limits research. Meanwhile, several less pathogenic human coronaviruses (HCoV) exist and can be studied in much more common biosafety level 2 laboratories. Among them, HCoV-OC43 is a good surrogate candidate for SARS-CoV-2 since both are phylogenetically related human . However, one issue has been the lack of standardized means among laboratories to propagate and titer this less virulent coronavirus. The present study probes the optimal parameters to propagate HCoV-OC43. First, testing of five different cell lines (MRC-5, Huh7.5, Vero, HCT-8, HRT-18) indicated that the physiologically relevant MRC-5 human lung cell line produced among the highest viral titers. HRT-18 may however be an interesting alternative as they are quick growing cells that also led to higher viral titers and a better tropism for various HCoV-OC43 variants. We also probed the impact of serum and temperature during viral expansion and confirmed that the normal temperature of the upper respiratory track (33 °C) improves viral yields over the typical 37 °C used to grow many other viruses. Meanwhile, we did not notice any evidence that serum concentrations significantly affected the virus but interestingly noted that the virus grew quite efficiently in a serum-free media formulation. Meanwhile sonication of viral stocks somewhat improved viral titers. Four titration methods (plaque assays, TCID-CPE, TCID-IFA and TCID-IPA) were also probed using two cell lines (VeroE6 and HRT-18). In our hands, plaque assays proved unreliable and quantification of the virus by scoring CPE positive wells was significantly less sensitive than antibody-based assays (IFA and IPA). While the latter methods were equally sensitive, we favor the TCID-IPA method since simpler, faster and cheaper than the IFA protocol. Moreover, the HRT-18 cells appeared more sensitive to quantify the virus. Perhaps most importantly, these optimized protocols routinely led to high titer viral stocks in the order of 10 TCID/ml magnitude, which should fulfill the requirements of most experimental settings.
冠状病毒在过去的两年里一直是新闻的焦点。不幸的是,SARS-CoV-2,即 COVID-19 大流行的病原体,必须在生物安全级别 3 环境中进行操作,这极大地限制了研究。与此同时,存在几种致病性较低的人类冠状病毒(HCoV),并且可以在更为常见的生物安全级别 2 实验室中进行研究。其中,HCoV-OC43 是 SARS-CoV-2 的良好替代候选者,因为它们在进化上都与人类有关。然而,一个问题是,实验室之间缺乏标准化的方法来繁殖和滴定这种毒力较弱的冠状病毒。本研究探讨了繁殖 HCoV-OC43 的最佳参数。首先,对五种不同细胞系(MRC-5、Huh7.5、Vero、HCT-8、HRT-18)的测试表明,生理相关的 MRC-5 人肺细胞系产生的病毒滴度最高。然而,HRT-18 可能是一种有趣的替代方法,因为它们是生长迅速的细胞,也导致了更高的病毒滴度和对各种 HCoV-OC43 变体的更好的嗜性。我们还探讨了血清和温度在病毒扩增过程中的影响,并证实上呼吸道温度(33°C)比用于生长许多其他病毒的典型温度 37°C 更能提高病毒产量。同时,我们没有发现任何证据表明血清浓度会显著影响病毒,但有趣的是注意到病毒在无血清培养基配方中生长效率相当高。同时,病毒储备的超声处理在一定程度上提高了病毒滴度。我们还使用两种细胞系(VeroE6 和 HRT-18)对四种滴定方法(噬斑测定法、TCID-CPE、TCID-IFA 和 TCID-IPA)进行了探究。在我们的手中,噬斑测定法被证明是不可靠的,与基于抗体的测定法(IFA 和 IPA)相比,对 CPE 阳性孔进行评分的病毒定量灵敏度明显较低。虽然后两种方法同样敏感,但我们更喜欢 TCID-IPA 方法,因为它比 IFA 方案更简单、更快、更便宜。此外,HRT-18 细胞似乎对定量病毒更敏感。也许最重要的是,这些优化的方案通常导致 10 TCID/ml 数量级的高滴度病毒储备,这应该满足大多数实验设置的要求。